Data Snack | March 2023

Time in Range Outcomes from Six European Countries

Our European research uncovered interesting outcomes related to patients’ Time in Range (TIR) – the amount of time spent with blood glucose values in their target range, which is typically between 70 and 180 mg/dL.

We discovered that across all dQ&A Community Members in Italy, Germany, the Netherlands, Sweden, the United Kingdom, and France, 45% of patients report achieving >70% TIR.

It is notable that there are significant differences between countries studied. A greater number of respondents in Italy (53%), Germany (51%), and the Netherlands (50%) achieve >70% TIR than those in Sweden (46%), the United Kingdom (39%), and France (32%).

Multiple health outcomes are associated with spending greater Time in Range. But some of those reported by our dQ&A EU Community Members are:

  • Better Sleep Quality: PWD with TIR >70% are more likely to be satisfied with their sleep, have refreshing sleep, get enough sleep on an average night, and have “good” sleep quality than those with TIR ≤70%.
  • Lower Emotional Burden: PWD with TIR >70% report having a lower emotional burden than those with TIR ≤70%. Meaning a significantly greater percent of respondents with TIR ≤70% feel that diabetes management takes too much effort, feel unmotivated and overwhelmed by their diabetes, and feel burnt out by diabetes management than those with TIR >70%.
  • Decreased Experience with Stigma: PWD with TIR >70% report having more infrequent stigma experiences than those with TIR ≤70%. A significantly greater percent of respondents with TIR ≤70% report that they feel embarrassed because of their diabetes, they find it hard to tell others, and they feel alone because of their diabetes than those with TIR >70%.

We are interested in how patients, providers, and payers could leverage the panoply of devices and therapies to achieve better outcomes and how those of us in the industry could assist.

About dQ&A – The Diabetes Research Company

dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at For research highlights, visit us at and follow us on LinkedIn (dQ&A – The Diabetes Research Company)